Buscar resultados de ensayos clínicos

Patrocinado por

Anaplastic Oligodendroglioma - 21 Studies Found

Estado Estudiar
Completed Nombre del estudio: Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma
Condición:
  • Anaplastic Astrocytomas
  • Anaplastic Oligodendrogliomas
  • Fecha: 2012-08-02
    Intervenciones: Drug: Etirinotecan pegol Other Name: NKTR-102
Not yet recruiting Nombre del estudio: Phase 1 Two Part Dose Escalation Trial of RRx-001 + Radiation + Temozolomide and RRx-001 + Temozolomide Post-RT In Newly Diagnosed Glioblastoma and Anaplastic Gliomas
Condición:
  • Glioblastoma
  • Oligodendroglioma
  • Anapl
    Fecha: 2016-08-11
    Intervenciones:
    • Drug: RRx-001 dose escalation with TMZ + RT

Terminated Nombre del estudio: Examination of Changes on Magnetic Resonance Imaging (MRI) and Magnetic Resonance Spectroscopy (MRS) in Patients Who Receive Gliadel Wafers During Initial Surgery for Glioblastoma Multiforme. Response or Failure to Gliadel Wafers for Subjects With Glioblastoma Multiforme.
Condición:
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Fecha: 2008-03-20
    Intervenciones: Other: MRS Spectroscopy Magnetic Resonance Spectroscopy us
Recruiting Nombre del estudio: Carboplatin in Treating Patients With Recurrent High-Grade Gliomas
Condición:
  • Adult Anaplastic Astrocytoma
  • Adult Anaplastic Oligodendroglioma
    Fecha: 2012-07-17
    Intervenciones:
    • Drug: carboplatin Carboplatin

Completed Nombre del estudio: A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
Condición:
  • Glioblastoma
  • Gliosarcoma
  • Anaplastic Astrocytoma
  • Fecha: 2008-08-13
    Intervenciones: Drug: Nanoliposomal CPT-11 Depending on UGT1A1 genotyping status, patients are either given a starting d
Completed Nombre del estudio: A Safety Study of RTA 744 in Patients With Recurrent High-Grade Gliomas
Condición: Glioma
Fecha: 2007-09-07
Intervenciones:
  • Drug: RTA 744 Aqueous solution
Suspended Nombre del estudio: Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
Condición:
  • Anaplastic Astrocytoma
  • Anaplastic Oligodendroglioma
  • Fecha: 2006-10-18
    Intervenciones:
    • Biological: Carcinoembryonic Antigen-Expressing Measles Virus

Terminated Nombre del estudio: Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
Condición:
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Fecha: 2003-06-06
    Intervenciones: Drug: Talampanel 10mg, 25 mg, 35 mg, 50 mg, 75mg TID for 3 weeks
Active, not recruiting Nombre del estudio: Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
Condición:
  • Adult Anaplastic Oligodendroglioma
  • Adult Giant Cell Glioblastom
    Fecha: 2012-05-30
    Intervenciones:
    • Drug: Bevacizumab 10 mg/kg on

Terminated Nombre del estudio: RO4929097 in Treating Patients With Recurrent Invasive Gliomas
Condición:
  • Adult Anaplastic Oligodendroglioma
  • Adult Brain Stem Glioma

    • Fecha: 2010-12-31
    Intervenciones:
    • Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097

<<< Previous | Next >>>